We are live on ! Find out more
INAB icon

IN8bio
INAB

Fund managers haven’t disclosed any holdings of INAB yet.

INAB Hedge Fund Activity: Q1 2026 in Review

19 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q1 2026, worth a combined $5.55M — down 25% from $7.45M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of INAB and 3 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Stonepine Capital Management, adding an estimated $964K. The largest seller was BIOS Capital Management, cutting an estimated $166K.

  • 19 institutional investors held IN8bio (INAB) as of Q1 2026, down from 22 in Q4 2025.
  • Funds reported $5.55M of IN8bio stock for Q1 2026, down 25% quarter-over-quarter.
  • 3 funds opened new IN8bio positions in Q1 2026 and 5 closed out, a net change of -2 holders.
  • The largest IN8bio buyer in Q1 2026 was Stonepine Capital Management, an estimated $964K added.
  • The largest IN8bio seller in Q1 2026 was BIOS Capital Management, an estimated $166K sold.

Based on aggregated 13F filings for Q1 2026.